EGFR and glioblastoma: In addition, while fluorescently tagged anti-EGFR antibodies have been in other studies to guide oncologic surgery in colon cancer, pancreatic cancer, and glioblastoma, these studies lack the power to determine optimal dosing for HNC studies.